A substantial body of evidence has prompted the concept that IDO2 might act as a pro-inflammatory mediator in autoimmune diseases, specifically autoimmune arthritis (30–32), systemic lupus erythematosus (33) and in contact hypersensitivity (29). The gene discussed is IDO2; the disease is systemic lupus erythematosus.